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Abstract: The purpose of this study was to quantify the time-magnitude changes in cardiometabolic
health outcomes that occur with cessation of regular exercise training. All participants (n = 22)
performed baseline testing, completed a 13-week exercise program, and completed post-program
testing. Upon completion of the 13-week exercise program, participants were randomized to one
of the following two treatment groups: (1) the treatment group that continued their exercise for
4 weeks (TRAIN); or (2) the treatment group that discontinued exercise (DETRAIN). Changes from
baseline to 13 weeks in both the TRAIN and DETRAIN treatment groups for maximal oxygen
consumption (VO2max), body fat percentage, mean arterial pressure, high-density lipoprotein (HDL)
cholesterol, and triglycerides were significantly favourable (p < 0.05). VO2max, body fat percentage,
and favourable cardiometabolic health adaptations continued to improve (p < 0.05) with an additional
one month of exercise training. Upon cessation of exercise, all measures of VO2max and body
fat percentage, along with mean arterial pressure, HDL cholesterol, and triglycerides significantly
worsened (p < 0.05) in the DETRAIN treatment group. Favourable training adaptations were further
enhanced with an additional month of continued exercise training, and cessation of regular exercise
rapidly abolished all training adaptations within one month. These novel findings underscore the
importance of sustained and uninterrupted exercise training.
Keywords: physical inactivity; metabolic syndrome; cardiorespiratory fitness; resistance training;
aerobic training
1. Introduction
There is a robust inverse relationship between cardiorespiratory fitness (CRF) and risk of mortality
from cardiovascular disease (CVD) and all causes [1]. For example, a one metabolic equivalent (1-MET)
increase in CRF in low-risk middle aged men and women is reported to promote an 18% reduction in
CVD mortality [2]. Therefore, increasing CRF via exercise training and increased physical activity (PA)
is a pertinent public health prevention measure to improve CVD-free survival in low risk adults.
Findings from numerous epidemiological studies clearly demonstrate that physical inactivity
is associated with a higher prevalence of most CVD risk factors, including abnormal lipids, high
blood pressure (BP), metabolic syndrome (MetS), obesity, and type 2 diabetes [3]. Furthermore,
physical inactivity is linked to most prevalent chronic diseases and is estimated to contribute to
approximately 250,000 premature deaths annually, representing approximately one quarter of all
preventable deaths [4].
Int. J. Environ. Res. Public Health 2018, 15, 2303; doi:10.3390/ijerph15102303 www.mdpi.com/journal/ijerph
Int. J. Environ. Res. Public Health 2018, 15, 2303 2 of 11
However, the majority of research linking either CRF or physical inactivity to disease risk
or cardiometabolic risk factors has focused on data collected at various time points with little
standardization of the days or weeks prior to data collection [5]. Furthermore, most research has
collected follow-up data in the 48–72 h following the last exercise bout [6]. While this research has
been valuable in promoting exercise in the public health domain, it is still unclear what the effects of
intermittent periods of increased activity or inactivity are on improvements in cardiometabolic health
following standardized aerobic exercise training periods of 12–24 weeks [6,7]. This is problematic,
as periodic activity or inactivity more closely mimics the fluctuation in activity levels in individuals as
they go about their daily lives. Common issues such as low initial fitness, low motivation, seasonal
holidays, travel, injury, and illness have all been cited [6] as reasons for low adherence or cessation of
exercise training. Thus evaluation of the effect of stopping an exercise intervention on cardiometabolic
health in apparently healthy adults is an important area to understand.
Accordingly, the purpose of this study was to examine the cardiometabolic health implications
with detraining after a regular exercise-training program. The main aim was to quantify the
time-magnitude changes in CRF and cardiometabolic health outcomes that occur with cessation
of regular exercise training. It was hypothesized that CRF and cardiometabolic health will decline
rapidly with the absence of regular exercise training over a one-month timeframe.
2. Materials and Methods
Thirty-five non-smoking men and women (aged 22 to 77 years) were recruited into the study
if they were of low-to-moderate risk as defined by the American College of Sports Medicine [7]
and not physically active (not participating in at least 30 min of moderate intensity physical activity
on at least three days of the week for at least three months). Participants were also eligible for
inclusion into the study if they verbally agreed to continue previous dietary habits and not perform
additional exercise beyond that required for the present study. Exclusionary criteria included evidence
of CVD, or pulmonary, and/or metabolic disease as determined by medical history questionnaire.
This study was approved by the Human Research Committee at Western State Colorado University
(HRC2017-01-01R20). Each participant signed an informed consent form prior to participation.
All participants performed baseline testing as outlined below and completed an individualized
13-week exercise program (Figure 1) according to the American Council of Exercise (ACE) Integrated
Fitness Training (IFT) model guidelines [8], and completed post-program testing. Upon completion
of the 13-week exercise training program and post-program testing participants were randomized to
either of the following two treatment groups: The continued training group (TRAIN, n = 17) continued
their individualized exercise program according to the ACE IFT model guidelines for an additional four
weeks and; the ceased treatment group (DETRAIN, n = 18) discontinued regular exercise. Participants
in DETRAIN did not perform any structured exercise whatsoever for four weeks; however, they were
permitted to maintain other lifestyle habits (e.g., nutrition and activities of daily living).
All variables were measured at the initial assessment and following the 13 weeks of exercise
training. In the detraining period, CRF and skinfold assessment occurred at weeks two and four only.
Measures of BP, blood lipids, fasting blood glucose, waist circumference, and weight were obtained in
each of the four weeks during the post-exercise training period.
Participants completed a maximum graded exercise test (GXT) on a motorized treadmill (Powerjog
GX200, Inspire Fitness Solutions Ltd., Biddeford, ME, USA). Participants walked or jogged at a
self-selected pace before the treadmill incline was increased by 1% every minute until the participant
reached volitional fatigue. Participants heart rate (HR) were continuously recorded via a chest strap
and radio-telemetric receiver (Polar Electro, Woodbury, NY, USA). Expired air and gas exchange data
were recorded continuously using a metabolic analyser (Parvo Medics TrueOne 2.0, Parvo Medics Inc.,
Salt Lake City, UT, USA). Before each exercise test, the metabolic analyser was calibrated with gases
of known concentrations (14.01 ± 0.07% O2, 6.00 ± 0.03% CO2) and with room air (20.93% O2 and
0.03% CO2) as per the instruction manual. Volume calibration of the pneumotachometer was done via
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a 3-litre calibration syringe system (Hans-Rudolph, Kansas City, MO, USA). The last 15 s of the GXT
were averaged—This was considered the final data point. The closest neighbouring data point was
calculated by averaging the data collected 15 s immediately before the last 15 s of the test. The mean of
the two processed data points represented the VO2max. The criteria for attainment of maximal oxygen
consumption (VO2max) were two out of three of the following: (1) a plateau (∆VO2 ≤ 150 mL/min) in
VO2 with increases in workload; (2) maximal respiratory exchange ratio (RER) ≥ 1.1; and (3) maximal
HR within 15 beats/min of the age-predicted maximum (220–age).
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RT 3 days 25 min/day 
Weeks 9–13 
RT 3 days 30 min/day 
Week 5–6 
RT 2 days 20 min/day 
Week 4 
RT 2 days 15 min/day 
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HR < VT1   3 days 30 min/day 
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Week 4 
HR < VT1   5 days 35 min/day 
Figure 1. Week-to-week ex rcise prescription for days/times of cardiorespiratory (left-hand side) and
resistance traini g (RT) (right-hand side). HR—heart ate, VT—ventilatory threshold.
Determination of both the first ventilatory threshold (VT1) and second ventilatory threshold (VT2)
were made by visual inspection of graphs of time plotted against each relevant respiratory variable
(according to 15 s time-averaging). The criteria for VT1 was an increase in VE/VO2 with no concurrent
increase in VE/VCO2 and departure from the linearity of VE. The criteria for VT2 was a simultaneous
increase in both VE/VO2 and VE/VCO2. The corresponding HRs at VT1 and VT2 were used to
improve the robustness of the exercise training response as has been shown elsewhere [1]. All analysis
to determine the VTs were done independently by two experienced exercise physiologists. In the event
of conflicting results, the original assessments were re-evaluated and collectively a consensus was
agreed upon.
Participants w re w ighed to the nearest 0.1 kg on a medical grade scale and measured for height
to the nearest 0.5 cm using a stadiometer. Percent body fat (FAT) was d termin d via skinfold [7].
Skinfold thickness was measured to the nearest ±0.5 mm using a Lange calliper. All measurements
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were taken on the right side of the body using standardized anatomical sites (three-site) for men (chest,
abdomen, thigh) and women (tricep, suprailiac, thigh). These measurements were performed until
two were within 10% of each other. All skinfold measures were obtained by the same qualified clinical
exercise physiologist. Waist circumference (WC) measurements were obtained using a cloth tape
measure with a spring loaded-handle. A horizontal measurement was taken at the narrowest point of
the torso (below the xiphoid process and above the umbilicus). These measurements were taken until
the two were within 0.5 mm of each other.
A fasting blood sample was collected and analysed for measurement of lipids and glucose.
A fingerstick sample was collected into heparin-coated 40-µL capillary tube. Blood flowed freely
from the fingerstick into the capillary tube without milking of the finger. Samples were dispensed
immediately onto commercially available test cassettes for analysis in a Cholestech LDX System
(Abbott Ltd., Chicago, IL, USA) according to strict standardized operating procedures.
The procedures for assessment of resting HR and BP outlined elsewhere were followed [7] and
collected in a standardized manner. The mean of the two measurements was reported for baseline and
post-program values.
2.1. Cardiometabolic Health
Cardiometabolic risk was determined via calculation of a MetS z-score following the procedure
outlined and used elsewhere. Briefly, this score is the sum of the participant’s MetS components relative
to the threshold for determination of each component. The MetS z-score has been used previously to
identify changes in MetS risk factors following an exercise intervention [9,10]. The sex-specific MetS
z-scores were calculated using the following equations [9,10]: (1) MetS z-scoremen = [(40 − HDL)/8.9] +
[(TG − 150/69)] + [(FG − 100)/17.8] + [(WC − 102)/11.5] + [(MAP − 100)/10.1]; (2) MetS z-scorewomen
= [(50 − HDL)/14.5] + [(TG − 150/69)] + [(FG − 100)/17.8] + [(WC − 88)/12.5] + [(MAP − 100)/10.1],
where FG = fasting glucose; HDL = high-density lipoprotein cholesterol; MAP = mean arterial pressure;
TG = triglycerides; and WC = waist circumference.
2.2. Exercise Prescription
All exercise was supervised one-to-one by student-trainers under the supervision of an
experienced researcher. No specific motivation strategies were employed, and participants were
booked in for their training at individual times according to their preferences and availability. Exercise
training was progressed according to recommendations made elsewhere by ACE [8] and implemented
in previous research [11,12]. Polar HR monitors were used to monitor HR during all exercise sessions.
Researchers adjusted workloads on aerobic modalities accordingly during each exercise session
to ensure actual HR responses aligned with target HR. The week-to-week exercise prescription
for cardiorespiratory and resistance training (RT) modes are provided in Figure 1 for the 13-week
exercise programme.
2.3. Statistical Analyses
Measures of centrality and spread are presented as mean ± SD. Paired t-tests were used to
determine mean within-group differences between baseline and week 13 for all physical fitness and
cardiometabolic health outcome measurements. Independent t-tests were performed to compare
treatment group (TRAIN vs. DETRAIN) at baseline and week 13 for all physical fitness and
cardiometabolic health outcome measurements.
Post-Training Period
Repeated measures ANOVA were performed for the TRAIN and DETRAIN groups for all
variables listed in Table 1 with the exception of height and age. Repeated measures were used
to compare differences in the change (from baseline) at the end of training, and each week of the
post-training period for CRF, FAT, MetS z-score, HDL, TG, BG, MAP, and WC. Unpaired t-tests were
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performed to determine group differences between TRAIN and DETRAIN for each time point in the
post-training period. One-way ANOVA was performed to determine the main effect of time for the
TRAIN and DETRAIN groups during the post-training period. Pairwise comparison analyses were
utilized to determine where significant differences existed between each time point.
Statistical significance was set at α = 0.05 for all analyses. All analyses were performed using SPSS
Version 25.0 (IBM, Chicago, IL, USA) and GraphPad Prism 7.0 (GraphPad Software Inc., San Diego,
CA, USA).
Table 1. Anthropometric, cardiometabolic risk, and cardiorespiratory fitness data for the TRAIN and
DETRAIN groups before and immediately after the 13-week exercise training programme.
Parameter
TRAIN (n = 12) DETRAIN (n = 10)
Baseline 13 Weeks Baseline 13 Weeks
Age (years) 40 ± 3 ____ 36 ± 5 ____
Height (cm) 167.9 ± 1.9 ____ 169.7 ± 4.0 ____
Weight (kg) 78.1 ± 8.6 78.9 ± 7.3 72.7 ± 16.2 72.2 ± 16.1
Waist circumference (cm) 86.5 ± 6.7 84.5 ± 3.6 81.7 ± 11.2 79.8 ± 10.1
Body fat (%) 31.1 ± 6.5 27.0 ± 2.2 * 28.5 ± 7.0 25.8 ± 9.1 *
VO2max (mL·kg−1·min−1) 30.6 ± 8.4 34.2 ± 8.7 * 33.7 ± 9.4 36.3 ± 7.4 *
Systolic BP (mmHg) 120 ± 4 ¥ 117 ± 6 * 113 ± 8 108 ± 14
Diastolic BP (mmHg) 82 ± 10 ¥ 80 ± 7 72 ± 8 74 ± 7
Total cholesterol (mg·dL−1) 163 ± 34 177 ± 25 * 188 ± 36 201 ± 34
HDL cholesterol (mg·dL−1) 55 ± 11 61 ± 14 * 57 ± 15 63 ± 15 *
LDL cholesterol (mg·dL−1) 89 ± 29 95 ± 19 112 ± 33 125 ± 41 *
Triglycerides (mg·dL−1) 114 ± 28 97 ± 27 * 112 ± 34 92 ± 23
Blood glucose (mg·dL−1) 92 ± 9 92 ± 11 92 ± 8 92 ± 7
MetS z-score −3.8 ± 1.9 ¥ −5.1 ± 1.9 ¥,* −5.9 ± 2.1 −7.0 ± 1.9 *
Data displayed as mean ± SD, * Within-group (TRAIN and DETRAIN) is significantly different from baseline,
p < 0.05. ¥ Between-group difference (baseline and 13 weeks), p < 0.05. BP: blood pressure; HDL: high-density
lipoprotein; LDL: low-density lipoprotein; MetS: metabolic syndrome; VO2max: maximal oxygen consumption.
3. Results
All analyses and data presented in the results are for those participants who completed the
investigation and full data sets were available. Six participants were unable to complete the
initial 13-week training period for the following reasons: personal reasons (n = 3), illness (n = 2),
and out-of-town move (n = 1). The dropout rate was greater in the TRAIN group (n = 4) vs. DETRAIN
group (n = 2). No adverse events due to the exercise training were reported in either group. A further
seven participants did not complete all testing sessions during the four week timeframe of continued
training or detraining and were therefore excluded from the analysis.
Overall, there was excellent compliance in both groups to the total number of prescribed training
sessions for the initial 13 weeks of exercise training: TRAIN group—mean, 88.7% (range, 77.4–96.8%)
and DETRAIN group—mean, 90.6% (range, 80.6–100.0%). Compliance in the TRAIN group for the
four weeks of continued exercise training was also excellent: mean, 91.3% (range, 80.0–100.0%).
The anthropometric, CRF, MetS Z-score, and individual cardiometabolic measures at baseline and
13 weeks for participants in both treatment groups are shown in Table 1.
After the initial 13 weeks of exercise training, there were significant changes in body fat percentage,
VO2max, HDL cholesterol, and MetS z-score in both groups. Systolic BP, total cholesterol, and TG
values were significantly different after 13 weeks in the TRAIN group only, whereas LDL cholesterol
was significantly different in the DETRAIN group only (all p > 0.05). After 13 weeks, the TRAIN and
DETRAIN treatment groups were only statistically significantly different in MetS z-score (p = 0.032).
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3.1. Maintain Regular Exercise Training
Anthropometric, cardiometabolic risk, and CRF measures at post-program and throughout the
one-month timeframe of continued exercise for the TRAIN group are shown in Table 2. CRF and
body fat percentage continued to improve (p < 0.05) with an additional one month of sustained
individualized exercise training. Moreover, after one month of continued regular exercise training,
the favourable adaptations in systolic BP, HDL cholesterol, and TG observed during the initial 13
weeks of exercise continued to be sustained (p > 0.05) although there was no further improvement
in MetS z-score (p > 0.05). Similar to the initial 13-week training block, all other measures (weight,
WC, diastolic BP, total cholesterol, LDL cholesterol, and BG) remained unchanged (p > 0.05) despite an
additional one month of exercise.
Table 2. Anthropometric, cardiometabolic risk, and cardiorespiratory fitness data for participants who
continued training (TRAIN) (n = 12) after the initial 13-week exercise training programme.
Parameter Post Program +1 Week +2 Weeks +3 Weeks +4 Weeks
Weight (kg) 78.9 ± 7.3 78.6 ± 7.1 78.4 ± 7.5 78.3 ± 7.2 78.0 ± 7.2
Waist circumference (cm) 84.5± 3.6 84.4 ± 3.7 84.3 ± 3.7 84.3 ± 3.9 84.0 ± 3.7
Body fat (%) 27.1 ± 2.2 ____ 26.7 ± 2.4 ____ 26.3 ± 2.2 *,¥
VO2max (mL·kg−1·min−1) 34.2 ± 8.7 ____ 35.5 ± 8.3 * ____ 36.5 ± 8.0 *,¥
Systolic BP (mmHg) 117 ± 6 116 ± 6 116 ± 6 116 ± 6 115 ± 6
Diastolic BP (mmHg) 80 ± 7 79 ± 6 79 ± 5 79 ± 6 79 ± 5
Total cholesterol (mg·dL−1) 177 ± 25 176 ± 23 178 ± 23 178 ± 24 180 ± 25
HDL cholesterol (mg·dL−1) 61 ± 14 63 ± 13 63 ± 13 63 ± 13 63 ± 13
LDL cholesterol (mg·dL−1) 94 ± 18 93 ± 18 94 ± 19 93 ± 17 93 ± 17
Triglycerides (mg·dL−1) 97 ± 27 96 ± 22 95 ± 21 96 ± 21 95 ± 20
Blood glucose (mg·dL−1) 92 ± 11 92 ± 9 91 ± 9 91 ± 10 91 ± 10
MetS z-score −5.1 ± 1.9 −5.3 ± 1.8 −5.4 ± 1.8 −5.4 ± 1.8 −5.5 ± 1.8
Data displayed as mean ± SD, * p < 0.05 from post-program, ¥ p < 0.05 from +2 weeks. BP: blood pressure;
HDL: high-density lipoprotein; LDL: low-density lipoprotein; MetS: metabolic syndrome; VO2max: maximal
oxygen consumption.
3.2. Detrain from Exercise Training
Anthropometric, cardiometabolic risk, and CRF measures at post-program and throughout the
one-month timeframe of continued exercise for the DETRAIN group are shown in Table 3. Upon
cessation of exercise training, VO2max, body fat percentage, HDL, TG, and MetS z-score significantly
worsened (p < 0.05). Weight, WC, systolic and diastolic BP, total cholesterol, LDL cholesterol, and BG
were unchanged (p > 0.05) during the one month follow-up period of physical inactivity.
Table 3. Anthropometric, cardiometabolic risk, and cardiorespiratory fitness data for participants that
detrained (DETRAIN) (n = 10) after the 13-week exercise training programme.
Parameter Post-Program +1 Week +2 Weeks +3 Weeks +4 Weeks
Weight (kg) 72.2 ± 16.1 72.4 ± 16.2 72.4 ± 16.5 72.6 ± 16.5 72.6 ± 16.5
Waist circumference (cm) 79.8 ± 10.1 79.4 ± 10.0 79.5 ± 10.1 79.4 ± 10.0 79.4 ± 9.9
Body fat (%) 25.8 ± 9.1 ____ 27.1 ± 8.5 ____ 28.8 ± 6.9 *
VO2max (mL·kg−1·min−1) 36.3 ± 7.4 ____ 35.4 ± 8.0 ____ 33.8 ± 8.9 *,¥
Systolic BP (mmHg) 108 ± 14 114 ± 9 115 ± 8 115 ± 8 115 ± 7
Diastolic BP (mmHg) 74 ± 7 75 ± 8 75 ± 8 75 ± 7 75 ± 8
Total cholesterol (mg·dL−1) 201 ± 34 200 ± 31 201 ± 31 202 ± 31 203 ± 31
HDL cholesterol (mg·dL−1) 63 ± 15 57 ± 17 * 57 ± 17 * 57 ± 17 * 57 ± 17 *
LDL cholesterol (mg·dL−1) 125 ± 41 125 ± 40 125 ± 40 125 ± 39 126 ± 40
Triglycerides (mg·dL−1) 92 ± 23 110 ± 40 112 ± 39 112 ± 37 * 112 ± 36 *
Blood glucose (mg·dL−1) 92 ± 7 93 ± 7 93 ± 7 93 ± 7 93 ± 7
MetS z-score −7.0 ± 1.9 −5.8 ± 2.1 * −5.9 ± 2.1 * −5.9 ± 2.1 * −5.7 ± 2.1 *
Data displayed as mean ± SD, * p < 0.05 from post-program, ¥ p < 0.05 from +2 weeks. BP: blood pressure;
HDL: high-density lipoprotein; LDL: low-density lipoprotein; MetS: metabolic syndrome; VO2max: maximal
oxygen consumption.
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3.3. Change in Cardiometabolic Health in the Post-Training Period
There were significant differences between the TRAIN and DETRAIN groups at each week in
the detraining period for change in MetS z-score (all p < 0.05)—see Figure 2 (panel A). Significant
differences exist between groups in HDL cholesterol (panel C), TG (panel D), and MAP (panel F) but
not WC (panel E), or BG (panel B). There was a significant effect of time on MetS z-score (panel A) and
HDL (panel C) only (p < 0.05).
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Figure 2. Change in MetS z-score (panel A) and the individual components of MetS z-score (panels
B–F) in previously sedentary adults who either detrained (DETRAIN; red bars, solid line), or trained
(TRAIN; blue bars, dotted lines). Please note that baseline is not included in statistical analysis but
included to indicate the change in the variable with the exercise training program. Data displayed
as mean ± S.E.M, * p < 0.05 comparison between groups, ¥ p < 0.05 compared with “end” time point
DETRAIN group. MetS: metabolic syndrome; BG: fasting blood glucose; HDL: high-density lipoprotein;
TG: triglycerides; MAP: mean arterial pressure.
3.4. Change in CRF and Body Fat Percentage in the Post-Training Period
Figure 3 displays the graphs of change in CRF (panel A) and body fat percentage (panel B) during
the post-training period for both the TRAIN and DETRAIN groups. There were significant differences
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in the change in CRF between the TRAIN and DETRAIN groups at both week 2 and week 4 in the
detraining period (both p < 0.005). The change in body fat percentage was only different between
groups at week 4 (p < 0.005). The main effect of time was significantly different at both week 2
(p = 0.015) and week 4 (p < 0.005) for change in CRF from end of training but only for week 4 (p = 0.038)
for the change in body fat percentage for the TRAIN group. The main effect of time was significantly
different at week 4 for change in CRF (p = 0.022) from end of training and for the change in body fat
percentage for the DETRAIN group (p = 0.033).
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Figure 3. Change in cardiorespiratory fitness (panel A) and body fat percentage (panel B) in previously
sedentary adults who either detrained (DETRAIN; red bars, solid line), or trained (TRAIN; blue bars,
dotted line). Please note that baseline is not included in statistical analysis but is included to indicate the
change in the variable with the exercise training program. Data displayed as mean ± S.E.M, * p < 0.05
comparison between groups, ¥ p < 0.05 compar d with “end” time p int DETRAIN group, € p < 0.05
com ared with “end” time point TRAIN group.
4. Discussion
The major finding of this study is the improvements in cardiometabolic health following 13 weeks
of exercise training reverted with one week of detraining. Secondary analyses of the relationship of
individual MetS components that contribute to cardiometabolic health reveal the deterioration with
detraining manifests chiefly due to a reduction in HDL cholesterol, an increase in TG concentration,
and a rise in MAP above the initial baseline level. Lastly, cessation f regular exercise rapidly abolished
all tra ni g adaptations with one month of detraining. These novel findings underscore the importance
of sustained and uninterrupted exercise training for improving cardiometabolic health and primary
prevention of chronic disease.
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4.1. Primary Prevention of Chronic Disease Perspective
In the past few decades low CRF has garnered considerable attention as an independent and
powerful predictor of CVD risk and premature mortality. For instance, Williams (2001) showed in a
meta-analysis that there was a marked decrease in relative risk for CVD when individuals moved out
of the lowest quartile of CRF [13]. Blair (2009) estimated that low CRF accounted for more overall
deaths when compared to deaths which could be attributed to traditional CVD risk factors, such as
obesity, smoking, hypertension, high cholesterol, and diabetes [14]. Accordingly, the changes in
CRF, as indicated by the measured VO2max, have clinical and public health relevance, as a large
number of adults fall into clinically-defined low CRF categories and therefore demonstrate increased
CVD risk [15]. Overall, VO2max improved on average by 1.69 METs following 17 weeks (1.03 METs
at 13 weeks) of exercise training in the TRAIN treatment group. These improvements likely have
important long-term prevention implications as a recent study reported a 1 MET increase in VO2max
was associated with an 18% reduction in deaths due to CVD [2]. However, the initial improvement in
VO2max (0.7 MET at 13 weeks) and likely reduced risk of CVD experienced in the DETRAIN treatment
group was rapidly lost upon 4-week cessation of exercise training (total change 0.02 METs).
A classic study from the early 1990s demonstrated the insidious outcomes from even small
interruptions to regular physical activity [16]. The researchers had a group of men perform 10 weeks
of single leg cycle ergometry at an intensity of 70% of their VO2max. This experimental design allowed
the untrained leg to serve as the control. After 10 weeks of training there was a 25% improvement in
insulin sensitivity in the trained leg, which corresponds to better blood glucose control. Remarkably,
all of the favourable training adaptations were lost after only six days without exercise.
Although there is almost universal agreement in the literature that various cardiometabolic health
indicators decline with the cessation of training [16–19], there is considerable variability reported on
which parameters change during the detraining period. Bajpeyi et al. (2009) reported improvements in
insulin sensitivity with eight months exercise training but different responses in insulin sensitivity due
to detraining depending on the exercise volume and intensity applied during the training period [17].
Similar to the current study, Nikseresht et al. (2016) reported a decreased HDL cholesterol with
detraining in middle aged obese men following 12 weeks of aerobic interval training (AIT), although
other blood lipid parameters did not show a decline with detraining [18]. Similarly, after four months
of AIT, Mora-Rodriguez et al. (2014) reported no change in WC, and a decline in HDL cholesterol and
CRF after one month of detraining [19]. However, Mora-Rodriguez reported the improvements in BP
with training were maintained in the detraining period in contrast to the current study [19].
While there is some discrepancy in the various cardiometabolic risk parameters, all studies
including the current study report a rapid decline (within days to weeks) in some of them with the
cessation of training. Decline in cardiometabolic health has been reported as occurring from six
days [16] to eight weeks [20] although it should be pointed out that these timelines are somewhat
arbitrary in that most studies have not looked at shorter or longer timeframes for data collection.
Unique to the current study however, the changes we saw in cardiometabolic health were most
prominent in the first week with a small degradation in the subsequent three weeks. This likely
indicates that in previous sedentary individuals, many of the health benefits associated with short-term
exercise training are lost rapidly and emphasis on longer-term training is required for the realization of
the primary prevention benefits of starting exercise. Collectively these findings point to the importance
of maintaining a persistent frequency of exercise training to maintain the cardiometabolic health
benefits related to exercise. Determining the minimum frequency, intensity, duration, and volume of
exercise to maintain the health benefits remains to be determined and represents important future
work in the area of exercise and cardiometabolic health.
4.2. Methodological Considerations
A few limitations to the present study warrant further discussion. First, while participants were
instructed to maintain their regular dietary intake during the 13-week intervention, diet intake was
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not strictly controlled for in this study. Second, physical activity/sedentary behaviour outside of the
training program and prescribed medications were not monitored, and thus may have influenced the
current findings. Third, participants were included in the study based on their sedentary behaviour
history and were not matched based on their cardiometabolic health. Between-group differences
do exist in some cardiometabolic health parameters that may have a small effect on the results.
This limitation may be overcome in future studies with larger participant numbers to improve the
generalizability of the results. Lastly, while we used a score of cardiometabolic health, apart from
sedentariness, the participants in this study were apparently healthy.
5. Conclusions
We have demonstrated that changes in cardiometabolic health are attainable in previously
sedentary individuals with short-term exercise training. However, the key finding in this study
is that in those people who subsequently detrained, the cardiometabolic health benefits were nearly
completely reversed within one week of detraining. This research highlights the importance of
sustained and uninterrupted exercise training for the realization of the public health benefits of
exercise in the prevention of chronic disease.
Author Contributions: Conceptualization, L.C.D. and P.B.N.; Methodology, S.M.K., C.A.R., C.A.B., and L.C.D.;
Formal Analysis, P.B.N. and L.C.D.; Investigation, S.M.K., C.A.R., and C.A.B.; Resources, C.A.B. and L.C.D.; Data
Curation, L.C.D.; Writing-Original Draft Preparation, P.B.N.; Writing-Review and Editing, P.B.N. and L.C.D.;
Visualization, L.C.D.; Supervision, L.C.D.; Project Administration, C.A.B. and L.C.D.; Funding Acquisition, L.C.D.
Funding: This research was funded by the American Council on Exercise.
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the design of the
study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to
publish the results.
References
1. Blair, S.N.; Kampert, J.B.; Kohl, H.W.; Barlow, C.E.; Macera, C.A.; Paffenbarger, R.S.; Gibbons, L.W. Influences
of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men
and women. J. Am. Med. Assoc. 1996, 276, 205–210. [CrossRef]
2. Barlow, C.E.; DeFina, L.F.; Radford, N.B.; Berry, J.D.; Cooper, K.H.; Haskell, W.L.; Jones, L.W.; Lakoski, S.G.
Cardiorespiratory fitness and long-term survival in “low-risk” adults. J. Am. Heart Assoc. 2012, 1, e001354.
[CrossRef] [PubMed]
3. Lavie, C.J.; Arena, R.; Swift, D.L.; Johannsen, N.M.; Sui, X.; Lee, D.C.; Earnest, C.P.; Church, T.S.; O’Keefe, J.H.;
Milani, R.V.; et al. Exercise and the cardiovascular system: Clinical science and cardiovascular outcomes.
Circ. Res. 2015, 117, 207–219. [CrossRef] [PubMed]
4. Booth, F.W.; Gordon, S.E.; Carlson, C.J.; Hamilton, M.T.; Frank, W.; Gordon, S.E.; Carlson, C.J. Waging war
on modern chronic diseases: Primary prevention through exercise biology. J. Appl. Physiol. 2000, 88, 774–787.
[CrossRef] [PubMed]
5. Lee, D.; Sui, X.; Church, T.S.; Lavie, C.J.; Jackson, A.S.; Blair, S.N. Changes in fitness and fatness
on the development of cardiovascular disease risk factors: Hypertension, metabolic syndrome,
and hypercholesterolemia. J. Am. Coll. Cardiol. 2012, 59, 665–672. [CrossRef] [PubMed]
6. Morales-Palomo, F.; Ramirez-Jimenez, M.; Ortega, J.F.; Lopez-Galindo, P.L.; Fernandez-Martin, J.;
Mora-Rodriguez, R. Effects of repeated yearly exposure to exercise-training on blood pressure and metabolic
syndrome evolution. J. Hypertens. 2017, 35, 1992–1999. [CrossRef] [PubMed]
7. Pescatello, L.S.; American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription, 9th ed.;
Wolters Kluwer/Lippincott Williams & Wilkins Health: Philadelphia, PA, USA, 2014.
8. Bryant, C.X.; Green, D.J. American Council on Exercise Personal Trainer Manual; American Council on Exercise:
San Diego, CA, USA, 2010.
9. Ramos, J.S.; Dalleck, L.C.; Borrani, F.; Beetham, K.S.; Wallen, M.P.; Mallard, A.R.; Clark, B.; Gomersall, S.;
Keating, S.E.; Fassett, R.G.; et al. Low-volume high-intensity interval training is sufficient to ameliorate the
severity of metabolic syndrome. Metab. Syndr. Relat. Disord. 2017, 15, 319–328. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2018, 15, 2303 11 of 11
10. Malin, S.K.; Nightingale, J.; Choi, S.E.; Chipkin, S.R.; Braun, B. Metformin modifies the exercise training
effects on risk factors for cardiovascular disease in impaired glucose tolerant adults. Obesity (Silver Spring)
2013, 21, 93–100. [CrossRef] [PubMed]
11. Wolpern, A.E.; Burgos, D.J.; Janot, J.M.; Dalleck, L.C. Is a threshold-based model a superior method to
the relative percent concept for establishing individual exercise intensity? A randomized controlled trial.
BMC Sports Sci. Med. Rehabil. 2015, 7, 16. [CrossRef] [PubMed]
12. Dalleck, L.C.; Haney, D.E.; Buchanan, C.A.; Weatherwax, R.M. Does a personalised exercise prescription
enhance training efficacy and limit training unresponsiveness? A randomised controlled trial. J. Fit. Res.
2016, 5, 15–27.
13. Williams, P.T. Physical fitness and activity as separate heart disease risk factors: A meta-analysis. Med. Sci.
Sports Exerc. 2001, 33, 754–761. [CrossRef] [PubMed]
14. Blair, S.N. Physical inactivity: The biggest public health problem of the 21st century. Br. J. Sports Med. 2009,
43, 1–2. [PubMed]
15. Lobelo, F.; Pate, R.R.; Dowda, M.; Liese, A.D.; Daniels, S.R. Cardiorespiratory fitness and clustered
cardiovascular disease risk in U.S. adolescents. J. Adolesc. Health 2010, 47, 352–359. [CrossRef] [PubMed]
16. Dela, F.; Mikines, K.J.; Von Linstow, M.; Secher, N.H.; Galbo, H. Effect of training on insulin-mediated glucose
uptake in human muscle 20. Am. J. Physiol. 1992, 263, E1134–E1143. [PubMed]
17. Bajpeyi, S.; Tanner, C.J.; Slentz, C.A.; Duscha, B.D.; McCartney, J.S.; Hickner, R.C.; Kraus, W.E.; Houmard, J.A.
Effect of exercise intensity and volume on persistence of insulin sensitivity during training cessation.
J. Appl. Physiol. 2009, 106, 1079–1085. [CrossRef] [PubMed]
18. Nikseresht, M.; Hafezi Ahmadi, M.R.; Hedayati, M. Detraining-induced alterations in adipokines and
cardiometabolic risk factors after nonlinear periodized resistance and aerobic interval training in obese men.
Appl. Physiol. Nutr. Metab. 2016, 41, 1018–1025. [CrossRef] [PubMed]
19. Mora-Rodriguez, R.; Ortega, J.F.; Hamouti, N.; Fernandez-Elias, V.E.; Cañete Garcia-Prieto, J.;
Guadalupe-Grau, A.; Saborido, A.; Martin-Garcia, M.; Guio de Prada, V.; Ara, I.; et al. Time-course effects of
aerobic interval training and detraining in patients with metabolic syndrome. Nutr. Metab. Cardiovasc. Dis.
2014, 24, 792–798. [CrossRef] [PubMed]
20. Liao, Y.H.; Sung, Y.C.; Chou, C.C.; Chen, C.Y. Eight-week training cessation suppresses physiological stress
but rapidly impairs health metabolic profiles and aerobic capacity in elite taekwondo athletes. PLoS ONE
2016, 11, e0160167. [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
